Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion

NCT ID: NCT03451318

Last Updated: 2018-04-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-02

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the efficacy and safety of drug therapy, tonsillar adenoidectomy only, orthodontic treatment only and tonsillar adenoidectomy plus orthodontic treatment in children with obstructive sleep apnea hypopnea syndrome (OSAHS) and malocclusion.

In this study, we hope to improve children's OSAH in function, three-dimensional shape and subjective and objective symptoms of sleep breathing through tonsillar adenoidectomy plus orthodontic treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Malocclusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

drug therapy

Nasonex(mometasone furoate),1 spray,QD (Quaque Die in Latin),for 3 months.

Group Type ACTIVE_COMPARATOR

Mometasone Furoate Nasal Spray

Intervention Type DRUG

Mometasone Furoate Nasal Spray NASONEX

tonsillar adenoidectomy

tonsillar adenoidectomy

Group Type ACTIVE_COMPARATOR

tonsillar adenoidectomy

Intervention Type PROCEDURE

tonsillar adenoidectomy

orthodontic treatment

Apply Twin-block appliance combined with maxillary expander

Group Type ACTIVE_COMPARATOR

Maxillary expander plus Twin-Block

Intervention Type PROCEDURE

Twin-block appliance combined with maxillary expander

tonsillar adenoidectomy plus orthodontic treatment

Apply Twin-block appliance combined with maxillary expander one month after tonsillar adenoidectomy .

Group Type ACTIVE_COMPARATOR

tonsillar adenoidectomy

Intervention Type PROCEDURE

tonsillar adenoidectomy

Maxillary expander plus Twin-Block

Intervention Type PROCEDURE

Twin-block appliance combined with maxillary expander

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mometasone Furoate Nasal Spray

Mometasone Furoate Nasal Spray NASONEX

Intervention Type DRUG

tonsillar adenoidectomy

tonsillar adenoidectomy

Intervention Type PROCEDURE

Maxillary expander plus Twin-Block

Twin-block appliance combined with maxillary expander

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosed as mild to moderate OSAHS
2. Tonsil and/or adenoid hypertrophy
3. Narrow dental arch and / or mandibular retrusion (ANB value≥ 4.5)
4. The guardian / child can understand the study and sign the informed consent

Exclusion Criteria

1. Patients with nasal obstruction disease
2. The pathological obesity
3. Patients with systemic disease
4. Patient with central sleep apnea/hypopnea syndrome
Minimum Eligible Age

4 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

Sponsor Role collaborator

Shanghai Children's Hospital

OTHER

Sponsor Role collaborator

Shanghai Stomotological Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuehua Liu, Professor

Role: PRINCIPAL_INVESTIGATOR

Department of Orthodonitcs,Shanghai Stomatological Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Stomotological Hospital

Shanghai, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuanyuan Li, Doctor

Role: CONTACT

86-18817367760

Huanbqing Shan

Role: CONTACT

86-13564158276

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yuanyuan Li, Doctor

Role: primary

18817367760

References

Explore related publications, articles, or registry entries linked to this study.

Li Y, Wu J, Guo J, Yu L, Wang J, Li X, Xu S, Zhu M, Feng J, Liu Y. The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: study protocol for a multicenter randomized controlled trial. Trials. 2020 Jun 30;21(1):595. doi: 10.1186/s13063-020-04398-9.

Reference Type DERIVED
PMID: 32605655 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16CR2044B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.